The effect of Hypbaric oxygen therapy in the treatment of hidradenitis suppurativa: a randomised controlled trial

Phase 3

• Conditions: acne inversa; fox-den disease; 10040792

• Registration Number: NL-OMON55331
• Lead Sponsor: Gelre Ziekenhuizen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Hurley stage IIB,IIc or III, men and women aged 18-60

Exclusion Criteria

History of pneumothorax, lung emphysema
Current otitis media
Inability to equalise ear pressure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Do HBOT improve wound healing in HS lesions?<br /><br>Outcome parameters: Hurley staging, Hidradenitis Suppurativa clinical response<br /><br>score, wound size reduction</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Does HBOT improve the quality of life in HS patients?<br /><br>Outcome parameter: dermatology quality of life index </p><br>